LARIDOX-AQ

This brand name is authorized in Nigeria.

Active ingredients

The drug LARIDOX-AQ contains a combination of these active pharmaceutical ingredients (APIs):

1	Amodiaquine UNII K6PW2S574L - AMODIAQUINE HYDROCHLORIDE
	Read more about Amodiaquine
2	Sulfadoxine UNII 88463U4SM5 - SULFADOXINE
	Read more about Sulfadoxine
3	Pyrimethamine UNII Z3614QOX8W - PYRIMETHAMINE
	Pyrimethamine is an antiparasitic agent. The antiparasitic action of pyrimethamine is due to its specific activity on folic acid metabolism in the Plasmodium and Toxoplasma parasites.
	Read more about Pyrimethamine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101235	Tablet	Laridox-AQ DT TAB 76.5 mg; 250 mg; 12.5 mg 25 x (3+1)'s (in PVC-Alu blisters)	Dispersible tablets LARIDOX-AQ DT(SULFADOXINE AND PYRIMETHAMINE DISPERSIBLE TABLETS(250MG/12.5MG) AND AMODIAQUINE DISPERSIBLE TABLETS 76.5MG) LARIDOX-AQ DT "(A)SULFADOXINE/PRIMETHAMINE 250MG/12.5MGDISPERSIBLE TABLETS, EXCIPIENTS ARE MICROCRYSTALLINE CELLULOSE, PREGELATINISED STARCH, COLLOIDAL SILICON DIOXIDE, CROPOVIDONE, POVIDONE, SUCRALOSE AND MAGNESIUM STEARATE (B) AMODIAQUINE (AS HYDROCHLORIDE) 76.5MG DISPERSIBLE TABLETS, EXCIPINETS ARE CROSCARMELLOSE SODIUM, MICROCRYSTALLINE CELLULOSE, POVIDONE,SUCRALOSE, SODIUM BICARBONATE,MAGNESIUM STEARATE.IT IS ESSENTIALLY SODIUM-FREE, IT CONTAINS LESS THAN 1 MMOL SODIUM(23MG) PER TABLET. " A4-101235 Drugs Imported Product 253+1 14-03-2025 IPCA PHARMA NIGERIA LIMITED, , OSOLO WAY AJAO ESTATE, LAGOS ISOLO LAGOS 08022389727 ipcapharma@yahoo.com "IPCA LABORATORIES LIMITED, PLOT NO 255/1 ATHAL SILVASSA PIN 396230(D&NH) INDIA	30/04/2025
A4-101236	Tablet	Laridox-AQ DT Forte TAB 153 mg; 500 mg; 25 mg 25 x (3+1)'s (in PVC-Alu blisters)	Dispersible tablet	30/04/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BA06	Amodiaquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BA Aminoquinolines
Discover more medicines within P01BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101235, A4-101236